Teva and licensee Lundbeck have announced positive results from two phase III clinical trials of rasagiline*

 

作者: &NA;,  

 

期刊: Inpharma Weekly  （ADIS Available online 2003）
卷期: Volume &NA;, issue 1381  

页码: 9-9

 

ISSN:1173-8324

 

年代: 2003

 

出版商: ADIS

 

数据来源: ADIS

 

 

返 回